Peric Mihaela, Bozdogan Bülent, Galderisi Chad, Krissinger Dan, Rager Terry, Appelbaum Peter C
Department of Pathology, Hershey Medical Center, Mail code H083, 500 University Dr., Hershey, PA 17033, USA.
J Antimicrob Chemother. 2004 Aug;54(2):393-400. doi: 10.1093/jac/dkh364. Epub 2004 Jul 8.
Haemophilus influenzae HMC-C with high-level macrolide resistance after multi-step selection by clarithromycin reverted spontaneously and became hypersusceptible to macrolides.
Determination of macrolide resistance mechanism(s) in hypersusceptible and hyperresistant strains.
The presence of macrolide efflux in the strains was studied by radioactive erythromycin accumulation. Ribosomal mutations were investigated by sequencing. The possible role of acrAB clusters in macrolide resistance was studied by sequencing and expression analysis.
The parent strain had no ribosomal alteration, but both high-level resistant and hypersusceptible strains had R88P mutations in ribosomal protein L22. Radioactive macrolide accumulation studies pointed to the presence of macrolide efflux in the high-level resistant and parent strains, but not in the hypersusceptible derivative. Transformation of hypersusceptible strains using total DNA from the parent strain restored the macrolide efflux system in the hypersusceptible strain, which was confirmed by MIC levels and radioactive erythromycin accumulation similar to that of the mutant resistant strain. Analysis of sequence and transcription of acrAB gene clusters showed no significant differences between resistant and hypersusceptible derivatives.
Mutation in ribosomal protein L22 alone does not confer high-level macrolide resistance unless efflux is present.
经克拉霉素多步筛选后具有高水平大环内酯类耐药性的流感嗜血杆菌HMC-C自发回复突变,对大环内酯类药物变得高度敏感。
确定高度敏感和高度耐药菌株中的大环内酯类耐药机制。
通过放射性红霉素积累研究菌株中大环内酯类药物外排情况。通过测序研究核糖体突变。通过测序和表达分析研究acrAB基因簇在大环内酯类耐药中的可能作用。
亲本菌株无核糖体改变,但高水平耐药菌株和高度敏感菌株的核糖体蛋白L22均有R88P突变。放射性大环内酯类药物积累研究表明,高水平耐药菌株和亲本菌株存在大环内酯类药物外排,而高度敏感衍生物中不存在。用亲本菌株的总DNA转化高度敏感菌株可恢复高度敏感菌株中的大环内酯类药物外排系统,这通过与突变耐药菌株相似的最低抑菌浓度水平和放射性红霉素积累得到证实。acrAB基因簇的序列和转录分析显示,耐药和高度敏感衍生物之间无显著差异。
单独的核糖体蛋白L22突变不会导致高水平大环内酯类耐药,除非存在外排。